SMTL ID : 8bx6.1

Crystal structure of JAK2 JH1 in complex with cerdulatinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x S5I: Cerdulatinib(Non-covalent)

S5I.1: 18 residues within 4Å: Chain A: L.39, G.40, K.41, G.42, V.47, A.64, V.95, M.113, E.114, Y.115, L.116, P.117, Y.118, G.119, S.120, D.123, K.127, L.167 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.39, A:V.47, A:A.64, A:Y.115, A:L.167 Hydrogen bonds: A:E.114, A:L.116, A:L.116

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Miao, Y. et al., Structural basis for JAK2 inhibition by clinical stage inhibitors. To Be Published

Release Date

2023-12-20

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence